LABU's +6% surge once again showed me what sector elasticity means. With the slightest movement in biotech, LABU directly "rocketed up", leaving those who missed out just watching from the sidelines. Hot news keeps coming, but frankly, XBI itself has been switching between highs and lows quite fiercely these past two days, making the rhythm hard to catch. When making money, I feel like a genius; when it pulls back, I immediately feel unlucky. Biotech is like a triple-leverage gambling table—too much gambling urge, itchy hands, and the fear is that after one surge, I’ll want to go all in. Will it still be my turn tomorrow?
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
